Company Profile

APTAGEN Labs is a global leader in aptamer development with over 30 years of experience generating high affinity and specifically-binding ligands for small molecules, proteins, cells, and tissues. We produce state-of-the-art target-recognition elements for synthetic biology, diagnostics, therapeutics, and bio-industrial applications.

Aptagen has grown from a one-man operation — with the ingenuity and support of interns, graduate students, and post-docs — to a tight-knit developing business with a world-class team of scientists, servicing clients ranging globally from research academics at top-tier institutions to BigPharma companies. Aptagen was named a finalist for "Top Emerging Business of the Year" of 2011 by Central Penn Business Journal.

Aptamers are an emerging technology poised to become the next evolution in diagnostics and drug discovery. Aptagen continues to play a leading role in developing aptamer technology that will assist in the treatment of disease and advance the life sciences.